Labori KJ, Bratlie SO, Dueland S, Lassen K(2024) NORPACT-1: implications for future trials - Authors' reply Lancet Gastroenterol Hepatol, 9(5), 408-409 DOI 10.1016/S2468-1253(24)00079-7, PubMed 38604194
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM(2024) Transient TCR-based T-cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer Mol Ther(in press) DOI 10.1016/j.ymthe.2024.04.009, PubMed 38582964
Hjermstad MJ, Jakobsen G, Arends J, Balstad T, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OMet al.(2024) Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series J Cachexia Sarcopenia Muscle(in press) DOI 10.1002/jcsm.13453, PubMed 38553255